Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells J Ma, X Li, Y Su, J Zhao, DA Luedtke, V Epshteyn, H Edwards, G Wang, ... Scientific reports 7, 41950, 2017 | 59 | 2017 |
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells G Wang, H Edwards, JT Caldwell, SA Buck, WY Qing, JW Taub, Y Ge, ... PloS one 8 (9), e76662, 2013 | 43 | 2013 |
Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo W Qi, W Zhang, H Edwards, R Chu, GJ Madlambayan, JW Taub, Z Wang, ... Cancer biology & therapy 16 (12), 1784-1793, 2015 | 40 | 2015 |
Synergistic anti-leukemic interactions between ABT-199 and panobinostat in acute myeloid leukemia ex vivo J Schwartz, X Niu, E Walton, L Hurley, H Lin, H Edwards, JW Taub, ... American journal of translational research 8 (9), 3893, 2016 | 32 | 2016 |
High level of mitogen‐activated protein kinase phosphatase‐1 expression is associated with cisplatin resistance in osteosarcoma Z Wang, JY Zhou, D Kanakapalli, S Buck, GS Wu, Y Ravindranath Pediatric blood & cancer 51 (6), 754-759, 2008 | 28 | 2008 |
Patterns of failure in patients with primary intracranial germinoma treated with neoadjuvant chemotherapy and radiotherapy P Paximadis, A Hallock, K Bhambhani, R Chu, S Sood, Z Wang, A Konski Pediatric neurology 47 (3), 162-166, 2012 | 21 | 2012 |
Targeting histone deacetylases (HDACs) and Wee1 for treating high‐risk neuroblastoma SS Hanmod, G Wang, H Edwards, SA Buck, Y Ge, JW Taub, Z Wang Pediatric blood & cancer 62 (1), 52-59, 2015 | 14 | 2015 |
Binding of Released Bim to Mcl-1 Is Responsible for Resistance to ABT-199 Which Can be Overcome By Combination with Daunorubicin or Cytarabine in Acute Myeloid Leukemia Cells X Niu, J Zhao, J Ma, C Xie, H Edwards, G Wang, JT Caldwell, R Chu, ... Blood 126 (23), 1265-1265, 2015 | 1 | 2015 |
Rhabdomyosarcoma with Central Nervous System Metastases: More Common than We Suspect? a Single-Institution's Experience K Hutchins, M Yankelevich, B Ozgonenel, R Chu, J Poulik, D Altinok, ... PEDIATRIC BLOOD & CANCER 64, S49-S50, 2017 | | 2017 |
HG-93CONCURRENT USE OF PANOBINOSTAT AND RE-IRRADIATION IN CHILDREN WITH PROGRESSIVE DIPG: REPORT OF 2 CASES Z Wang, Y Ge, D Altinok, J Poulik, S Sood, J Taub, H Pitman, M Kieran, ... Neuro-oncology 18 (Suppl 3), iii70, 2016 | | 2016 |
Is Biopsy Safe In Diffuse Intrinsic Pontine Glioma?-An Institutional Experience L Rao, K Miller, K Bhambhani, M Yankelevich, A Konski, D Altinok, ... Pediatric Blood & Cancer 60, S79, 2013 | | 2013 |
Cell Cycle And Apoptosis Regulatory Protein (carp)-1 Expression In Neuroblastoma S Hanmod, S Siegel, M Zidan, R Rabah, J Hatfield, E Levi, ... Pediatric Blood & Cancer 57 (5), 782, 2011 | | 2011 |
Significance Of Positive Fdg-avid Thoracic Lesions On Pet-ct In Children With Osteosarcoma B Ozgonenel, D Doganis, M Yankelevich, Z Wang, M Khalaf Pediatric Blood & Cancer 56 (6), 961-962, 2011 | | 2011 |
Gilbert's Syndrome As A Potential Risk Factor For Etv6/runx1 Positive Childhood Acute Lymphoblastic Leukemia (all) Y Ravindranath, I Brecht, F Nahhas, A Nahar, A Mohamad, Z Wang, ... Pediatric Blood & Cancer 55 (5), 850-851, 2010 | | 2010 |
Mkp-1 Expression And Cisplatin Resistance In Neuroblastoma Z Wang, D Kanakapalli, W Zhao, Y Zhuang, Y Ravindranath, R Rahah Pediatric Blood & Cancer 54 (6), 852, 2010 | | 2010 |
Increased nonclonal chromosome aberrations in a patient with gliosarcoma and secondary acute myeloid leukemia Z Wang, K Bhambhani, M Hamre, G Liu, C Ye, H Heng NEURO-ONCOLOGY 10 (3), 398-399, 2008 | | 2008 |